Abosheasha Mohammed A, Ito Yoshihiro, Ueda Motoki
Nano Medical Engineering Laboratory, RIKEN Cluster for Pioneering Research (CPR), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Department of Biological Sciences, Graduate School of Science, Tokyo Metropolitan University, 1-1 Minami-Osawa, Hachioji, Tokyo 192-0397, Japan.
Nanoscale. 2025 Oct 2;17(38):22529-22539. doi: 10.1039/d5nr02793d.
Utilizing biological membranes, such as red blood cells and extracellular vesicles, to create bio-camouflaged carriers presents a promising strategy for biomedical applications and drug delivery systems to evade the immune system and reach specifically targeted organs. In this report, as a preliminary study in carrier preparation, we aimed to transplant a lipid membrane from a general liposome-a model of a natural cell membrane-into a peptide vesicle composed of amphiphilic polydepsipeptides. Consequently, we successfully produced a peptide-lipid hybrid vesicle (PLHV) that consisted of phase-separated lipid and peptide membranes, exhibiting a diameter of 50-90 nm. The preparation method for the PLHV involved three simple steps: (1) preparing the liposome, (2) adding the amphiphilic polydepsipeptide, poly(Sar)-(L-Leu-Aib) (SL14), to the liposome dispersion, and (3) applying heat treatment at 90 °C for 1 hour. Emission quenching tests of NBD tethered to the membrane surface and FRET analysis indicated that the PLHV included an independent lipid domain distinct from the peptide domain, preserving the membrane asymmetry of the original liposome within this lipid domain. Although hybrid vesicles and liposomes had similar encapsulation efficiency, hybrid vesicles showed greater storage stability due to the rigidity of the peptide domain. This technology illuminates the development of drug delivery systems utilizing natural cell membranes.
利用生物膜,如红细胞和细胞外囊泡,来制造生物伪装载体,为生物医学应用和药物递送系统提供了一种有前景的策略,以逃避免疫系统并到达特定的靶向器官。在本报告中,作为载体制备的初步研究,我们旨在将普通脂质体(天然细胞膜的一种模型)的脂质膜移植到由两亲性聚(去)肽组成的肽囊泡中。因此,我们成功制备了一种肽 - 脂质混合囊泡(PLHV),它由相分离的脂质膜和肽膜组成,直径为50 - 90纳米。PLHV的制备方法包括三个简单步骤:(1)制备脂质体;(2)将两亲性聚(去)肽聚(Sar)-(L - Leu - Aib)(SL14)添加到脂质体分散液中;(3)在90℃下进行1小时的热处理。对连接到膜表面的NBD进行的发射猝灭测试和FRET分析表明,PLHV包含一个与肽结构域不同的独立脂质结构域,在该脂质结构域内保留了原始脂质体的膜不对称性。虽然混合囊泡和脂质体具有相似的包封效率,但由于肽结构域的刚性,混合囊泡表现出更高的储存稳定性。这项技术为利用天然细胞膜的药物递送系统的发展提供了启示。